References
[1] L. Vernacchio, J. P. Kelly, D. W. Kaufman, and A. A. Mitchell, “Medication use among children <12 years of age in the United States: results from the Slone Survey,” Pediatrics, vol. 124, no. 2, pp. 446–454, Aug. 2009, doi: 10.1542/peds.2008-2869.
[2] E. Tan, I. Braithwaite, C. J. D. McKinlay, and S. R. Dalziel, “Comparison of Acetaminophen (Paracetamol) With Ibuprofen for Treatment of Fever or Pain in Children Younger Than 2 Years: A Systematic Review and Meta-analysis,” JAMA Netw. Open, vol. 3, no. 10, p. e2022398, Oct. 2020, doi: 10.1001/jamanetworkopen.2020.22398.
[3] A. M. Fitzpatrick, D. P. Jones, and L. A. S. Brown, “Glutathione redox control of asthma: from molecular mechanisms to therapeutic opportunities,” Antioxid. Redox Signal., vol. 17, no. 2, pp. 375–408, Jul. 2012, doi: 10.1089/ars.2011.4198.
[4] S. L. Nuttall, J. N. Khan, G. H. Thorpe, N. Langford, and M. J. Kendall, “The impact of therapeutic doses of paracetamol on serum total antioxidant capacity,” J. Clin. Pharm. Ther., vol. 28, no. 4, pp. 289–294, Aug. 2003, doi: 10.1046/j.1365-2710.2003.00493.x.
[5] “Reye’s syndrome - Symptoms and causes,” Mayo Clinic. https://www.mayoclinic.org/diseases-conditions/reyes-syndrome/symptoms-causes/syc-20377255 (accessed Jan. 04, 2022).
[6] A. E. Varner, W. W. Busse, and R. F. Lemanske, “Hypothesis: decreased use of pediatric aspirin has contributed to the increasing prevalence of childhood asthma,” Ann. Allergy Asthma Immunol. Off. Publ. Am. Coll. Allergy Asthma Immunol., vol. 81, no. 4, pp. 347–351, Oct. 1998, doi: 10.1016/S1081-1206(10)63127-4.
[7] G. Thompson, C. Bundell, and M. Lucas, “Paracetamol allergy in clinical practice,” Aust. J. Gen. Pract., vol. 48, no. 4, pp. 216–219, Apr. 2019, doi: 10.31128/AJGP-08-18-4689.
[8] S. Schultz, G. G. Gould, N. Antonucci, A. L. Brigida, and D. Siniscalco, “Endocannabinoid System Dysregulation from Acetaminophen Use May Lead to Autism Spectrum Disorder: Could Cannabinoid Treatment Be Efficacious?,” Mol. Basel Switz., vol. 26, no. 7, p. 1845, Mar. 2021, doi: 10.3390/molecules26071845.
[9] A. G. Barbosa et al., “Assessment of BDNF serum levels as a diagnostic marker in children with autism spectrum disorder,” Sci. Rep., vol. 10, no. 1, p. 17348, Oct. 2020, doi: 10.1038/s41598-020-74239-x.
[10] A. Saghazadeh and N. Rezaei, “Brain-Derived Neurotrophic Factor Levels in Autism: A Systematic Review and Meta-Analysis,” J. Autism Dev. Disord., vol. 47, no. 4, pp. 1018–1029, Apr. 2017, doi: 10.1007/s10803-016-3024-x.
[11] K. Blecharz-Klin et al., “Early paracetamol exposure decreases brain-derived neurotrophic factor (BDNF) in striatum and affects social behaviour and exploration in rats,” Pharmacol. Biochem. Behav., vol. 168, pp. 25–32, May 2018, doi: 10.1016/j.pbb.2018.03.004.
[12] A. R. Torres, “Is fever suppression involved in the etiology of autism and neurodevelopmental disorders?,” BMC Pediatr., vol. 3, p. 9, Sep. 2003, doi: 10.1186/1471-2431-3-9.
[13] M. Etminan, M. Sadatsafavi, S. Jafari, M. Doyle-Waters, K. Aminzadeh, and J. M. FitzGerald, “Acetaminophen use and the risk of asthma in children and adults: a systematic review and metaanalysis,” Chest, vol. 136, no. 5, pp. 1316–1323, Nov. 2009, doi: 10.1378/chest.09-0865.
[14] L. Garcia-Marcos, M. Sanchez-Solis, and V. Perez-Fernandez, “Early exposure to acetaminophen and allergic disorders,” Curr. Opin. Allergy Clin. Immunol., vol. 11, no. 3, pp. 162–173, Jun. 2011, doi: 10.1097/ACI.0b013e3283464c28.
[15] M. Sherbash, L. Furuya-Kanamori, J. D. Nader, and L. Thalib, “Risk of wheezing and asthma exacerbation in children treated with paracetamol versus ibuprofen: a systematic review and meta-analysis of randomised controlled trials,” BMC Pulm. Med., vol. 20, no. 1, p. 72, Mar. 2020, doi: 10.1186/s12890-020-1102-5.
[16] S. M. Lesko and A. A. Mitchell, “The safety of acetaminophen and ibuprofen among children younger than two years old,” Pediatrics, vol. 104, no. 4, p. e39, Oct. 1999, doi: 10.1542/peds.104.4.e39.
[17] S. T. Schultz, H. S. Klonoff-Cohen, D. L. Wingard, N. A. Akshoomoff, C. A. Macera, and M. Ji, “Acetaminophen (paracetamol) use, measles-mumps-rubella vaccination, and autistic disorder: the results of a parent survey,” Autism Int. J. Res. Pract., vol. 12, no. 3, pp. 293–307, May 2008, doi: 10.1177/1362361307089518.
[18] S. S. Bittker and K. R. Bell, “Acetaminophen, antibiotics, ear infection, breastfeeding, vitamin D drops, and autism: an epidemiological study,” Neuropsychiatr. Dis. Treat., vol. 14, pp. 1399–1414, 2018, doi: 10.2147/NDT.S158811.
[19] S. Alemany et al., “Prenatal and postnatal exposure to acetaminophen in relation to autism spectrum and attention-deficit and hyperactivity symptoms in childhood: Meta-analysis in six European population-based cohorts,” Eur. J. Epidemiol., vol. 36, no. 10, pp. 993–1004, Oct. 2021, doi: 10.1007/s10654-021-00754-4.
[20] S. T. Schultz, “Can autism be triggered by acetaminophen activation of the endocannabinoid system?,” Acta Neurobiol. Exp. (Warsz.), vol. 70, no. 2, pp. 227–231, 2010.
[21] T. J. Metcalf, T. G. Irons, L. D. Sher, and P. C. Young, “Simethicone in the treatment of infant colic: a randomized, placebo-controlled, multicenter trial,” Pediatrics, vol. 94, no. 1, pp. 29–34, Jul. 1994.
[22] J. Piątek et al., “Effects of a nine-strain bacterial synbiotic compared to simethicone in colicky babies - an open-label randomised study,” Benef. Microbes, vol. 12, no. 3, pp. 249–257, Jun. 2021, doi: 10.3920/BM2020.0160.
[23] I. Alexandrovich, O. Rakovitskaya, E. Kolmo, T. Sidorova, and S. Shushunov, “The effect of fennel (Foeniculum Vulgare) seed oil emulsion in infantile colic: a randomized, placebo-controlled study,” Altern. Ther. Health Med., vol. 9, no. 4, pp. 58–61, Aug. 2003.
[24] S. M. Dimitratos, H. Brown, T. Shafizadeh, S. Kazi, T. Altmann, and B. Ostrer, “Symptomatic relief from at-home use of activated Bifidobacterium infantis EVC001 probiotic in infants: results from a consumer survey on the effects on diaper rash, colic symptoms, and sleep,” Benef. Microbes, vol. 12, no. 4, pp. 27–34, Aug. 2021, doi: 10.3920/BM2020.0229.
[25] A. A. Breakey, K. Hinde, C. R. Valeggia, A. Sinofsky, and P. T. Ellison, “Illness in breastfeeding infants relates to concentration of lactoferrin and secretory Immunoglobulin A in mother’s milk,” Evol. Med. Public Health, vol. 2015, no. 1, pp. 21–31, Jan. 2015, doi: 10.1093/emph/eov002.
[26] F. Hassiotou et al., “Maternal and infant infections stimulate a rapid leukocyte response in breastmilk,” Clin. Transl. Immunol., vol. 2, no. 4, p. e3, Apr. 2013, doi: 10.1038/cti.2013.1.